{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,11]],"date-time":"2026-10-11T17:25:23Z","timestamp":1791739523126,"version":"4.3.4"},"reference-count":36,"publisher":"SAGE Publications","issue":"2","license":[{"start":{"date-parts":[[2022,11,3]],"date-time":"2022-11-03T00:00:00Z","timestamp":1667433600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["J Diabetes Sci Technol"],"published-print":{"date-parts":[[2023,3]]},"abstract":"<jats:p>Although advances in insulin therapy and delivery have been made, global evidence indicates sub-optimal glycemic management in people on insulin therapy with either type 1 diabetes (T1D) or type 2 diabetes (T2D). In this review, we discuss connected insulin pens that include tracking insulin pens (TIPs) and smart insulin pens (SIPs) and caps, as approaches to improving mean glucose or time in range while minimizing exposure to hypoglycemia or time below range (TBR) in people with diabetes (PwD) on multiple daily injection (MDI) therapy. We discuss various factors offered by SIPs that can facilitate precision insulin management, that is, delivering the right dose at the right time. These factors include the automatic recording of insulin dose size and delivery time; differentiating prime from therapy doses; active insulin tracking; dose calculators that provide individualized dosing recommendations; alerts for missed doses (ie, rapid-acting or long-acting insulin), insulin temperature, and insulin age monitoring; and integrated data reports for the clinical care team. A data-driven approach to care is critical to precision insulin management and includes helping PwD make informed choices regarding their preferred method of insulin delivery and ensuring insulin delivery technology tools are configured for their personal therapy plan. The data-driven approach involves developing a plan for ongoing collaborative use of the resulting data with their care team that may include adjusting insulin regimen and optimizing the care plan on a timely basis. We conclude with a list of practice protocols that are needed to support data-driven precision insulin management. This review includes a summary of research including various stages of connected insulin pens and caps.<\/jats:p>","DOI":"10.1177\/19322968221134546","type":"journal-article","created":{"date-parts":[[2022,11,3]],"date-time":"2022-11-03T08:56:03Z","timestamp":1667465763000},"page":"283-289","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":23,"title":["A Review of Precision Insulin Management With Smart Insulin Pens: Opening Up the Digital Door to People on Insulin Injection Therapy"],"prefix":"10.1177","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8689-4938","authenticated-orcid":false,"given":"Janice","family":"MacLeod","sequence":"first","affiliation":[{"name":"Medtronic Diabetes, Northridge, CA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3546-3385","authenticated-orcid":false,"given":"Robert A.","family":"Vigersky","sequence":"additional","affiliation":[{"name":"Medtronic Diabetes, Northridge, CA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2022,11,3]]},"reference":[{"key":"bibr1-19322968221134546","unstructured":"Sikes KA, Weyman K. Diabetes and the use of insulin pumps. Endocrinology Advisor. https:\/\/www.endocrinologyadvisor.com\/home\/decision-support-in-medicine\/endocrinology-metabolism\/diabetes-and-the-use-of-insulin-pumps\/. Published January 2019. Accessed October 15, 2022."},{"key":"bibr2-19322968221134546","doi-asserted-by":"publisher","DOI":"10.1177\/1932296821997923"},{"issue":"5","key":"bibr3-19322968221134546","first-page":"21","volume":"17","author":"Kerr D","year":"2019","journal-title":"Endocr Today"},{"key":"bibr4-19322968221134546","doi-asserted-by":"publisher","DOI":"10.1089\/dia.2009.0178"},{"key":"bibr5-19322968221134546","unstructured":"International Organization for Standardization. Needle-based injection systems for medical use\u2014requirements and test methods\u2014part 1: needle-based injection systems (ISO 11608-1:2022). https:\/\/www.iso.org\/standard\/70733.html. Published January 2022. Accessed October 15, 2022."},{"key":"bibr6-19322968221134546","doi-asserted-by":"publisher","DOI":"10.1089\/dia.2019.0374"},{"key":"bibr7-19322968221134546","unstructured":"Food and Drug Administration. Companion medical InPen system (K160629) clearance letter. https:\/\/www.accessdata.fda.gov\/cdrh_docs\/pdf16\/K160629.pdf. Published July 26, 2016. Accessed October 15, 2022."},{"key":"bibr8-19322968221134546","doi-asserted-by":"publisher","DOI":"10.1080\/17425247.2017.1313831"},{"key":"bibr9-19322968221134546","doi-asserted-by":"publisher","DOI":"10.2337\/ds18-0069"},{"key":"bibr10-19322968221134546","doi-asserted-by":"publisher","DOI":"10.1016\/j.mayocp.2016.06.010"},{"key":"bibr11-19322968221134546","doi-asserted-by":"publisher","DOI":"10.1089\/dia.2021.0164"},{"key":"bibr12-19322968221134546","doi-asserted-by":"publisher","DOI":"10.1177\/1932296820973185"},{"key":"bibr13-19322968221134546","doi-asserted-by":"publisher","DOI":"10.2337\/db18-992-P"},{"key":"bibr14-19322968221134546","doi-asserted-by":"publisher","DOI":"10.2337\/dc18-1631"},{"key":"bibr15-19322968221134546","doi-asserted-by":"publisher","DOI":"10.1177\/193229680800200209"},{"key":"bibr16-19322968221134546","doi-asserted-by":"publisher","DOI":"10.1089\/dia.2019.0186"},{"key":"bibr17-19322968221134546","volume-title":"Poster (IP22) presentation at the Association of Diabetes Care & Education Specialists Virtual Conference","author":"Smith M"},{"key":"bibr18-19322968221134546","doi-asserted-by":"publisher","DOI":"10.1111\/j.1464-5491.2011.03466.x"},{"key":"bibr19-19322968221134546","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-148-10-200805200-00006"},{"key":"bibr20-19322968221134546","doi-asserted-by":"publisher","DOI":"10.2337\/diaclin.32.4.152"},{"key":"bibr21-19322968221134546","doi-asserted-by":"publisher","DOI":"10.1177\/1932296814532906"},{"key":"bibr22-19322968221134546","unstructured":"Companion Medical. FDA clears InPen diabetes management system for fixed dosing and meal estimation. Cision\u2122 PR Newswire. February 27, 2020. https:\/\/www.prnewswire.com\/news-releases\/fda-clears-inpen-diabetes-management-system-for-fixed-dosing-and-meal-estimation-301013128.html. Accessed October 15, 2022."},{"key":"bibr23-19322968221134546","volume-title":"Poster presentation at the Association of Diabetes Care & Education Specialists Virtual Conference","author":"Smith M"},{"issue":"2","key":"bibr24-19322968221134546","first-page":"A69","volume":"15","author":"Smith M","year":"2020","journal-title":"J Diabetes Sci Technol"},{"key":"bibr25-19322968221134546","doi-asserted-by":"publisher","DOI":"10.2337\/dci19-0028"},{"key":"bibr26-19322968221134546","doi-asserted-by":"publisher","DOI":"10.2337\/dc22-S007"},{"key":"bibr27-19322968221134546","doi-asserted-by":"publisher","DOI":"10.1177\/1932296820951225"},{"key":"bibr28-19322968221134546","doi-asserted-by":"publisher","DOI":"10.1177\/0145721720935125"},{"key":"bibr29-19322968221134546","doi-asserted-by":"publisher","DOI":"10.1177\/2633559X211032227"},{"key":"bibr30-19322968221134546","doi-asserted-by":"publisher","DOI":"10.1177\/1932296820984490"},{"key":"bibr31-19322968221134546","volume":"17","author":"Vigersky RA","year":"2021","journal-title":"Nature Milestones in Diabetes"},{"key":"bibr32-19322968221134546","unstructured":"Anirban R, Grosman B, Engel T, Miller D, et al. Eliminating advanced meal bolusing: a feasability trial using MiniMed\u2122 780G and hand gesture algorithms. Oral Presentation at the American Diabetes Association 82nd Scientific Sessions; 2022; San Diego, CA."},{"key":"bibr33-19322968221134546","doi-asserted-by":"publisher","DOI":"10.2337\/cd22-0068"},{"key":"bibr34-19322968221134546","doi-asserted-by":"publisher","DOI":"10.1177\/0145721720930183"},{"key":"bibr35-19322968221134546","doi-asserted-by":"publisher","DOI":"10.1016\/j.eprac.2021.04.576"},{"key":"bibr36-19322968221134546","doi-asserted-by":"publisher","DOI":"10.1007\/s13300-020-00980-1"}],"container-title":["Journal of Diabetes Science and Technology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/19322968221134546","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/19322968221134546","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/19322968221134546","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T18:16:10Z","timestamp":1777400170000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/19322968221134546"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,3]]},"references-count":36,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2023,3]]}},"alternative-id":["10.1177\/19322968221134546"],"URL":"https:\/\/doi.org\/10.1177\/19322968221134546","relation":{},"ISSN":["1932-2968","1932-2968"],"issn-type":[{"value":"1932-2968","type":"print"},{"value":"1932-2968","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,11,3]]}}}